Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,406 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

for
Neurofibromatosis Type 1
Location: St Louis MO, Indianapolis IN, Chicago IL, Cincinnati OH,
Sponsor: Healx Limited

Sex: All

Age: 12+

Code: NCT06541847

Phase 2, Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for
Metastatic Dedifferentiated Liposarcoma,
Location: St Louis MO, New Lenox IL, Orland Park IL, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase 1, Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: St Louis MO, Nashville TN, Chicago IL, Saint Paul MN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

for
Aortic Dissection, Aortic Aneurysm, Intramural Hematoma,
Location: St Louis MO, Nashville TN, Chicago IL, Cincinnati OH,
Sponsor: Endospan Ltd.

Sex: All

Age: 18+

Code: NCT04471909

Recruiting

Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer

for
Locally Advanced Cervical Carcinoma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 18+

Code: NCT06529809

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: St Louis MO, Iowa City IA, Kansas City KS, Nashville TN,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06001788

Phase 1, Recruiting

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Hematological Malignancies
Location: St Louis MO, Louisville KY, Little Rock AR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT04634552

Phase 2, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: St Louis MO, Kansas City MO, Nashville TN, Chicago IL,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase 1, Recruiting

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for
Hodgkin Lymphoma in Remission, Leukemia in Remission,
Location: St Louis MO, Peoria IL, Oak Lawn IL, Chicago IL,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT01790152

Recruiting

A Single-arm, Pivotal Study to Evaluate Acute Device and Technical Success of the CGuard Prime Carotid Stent System When Used in Conjunction to the ENROUTE Transcarotid Neuroprotection System in Patients Undergoing Carotid Artery Stenting Via the Transcarotid Artery Revascularization Approach

for
Carotid Artery Diseases
Location: Saint Louis MO, Indianapolis IN, Cincinnati OH,
Sponsor: InspireMD

Sex: All

Age: 18 - 70+

Code: NCT06653387

Recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06483100

Phase 2, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: St Louis MO, Weldon Spring MO, Indianapolis IN,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase 3, Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for
Solid Tumor
Location: St Louis MO, Westwood KS, Nashville TN, Madison WI,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase 1, Recruiting

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

for
Delirium
Location: St Louis MO, Iowa City IA, Nashville TN, Chicago IL,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 60+

Code: NCT06192615

Phase 3, Recruiting

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

for
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Location: St Louis MO, Indianapolis IN, Flowood MS, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05519475

Phase 2, Recruiting

Cryoablation vs Lumpectomy in T1 Breast Cancers

for
Breast Cancer, Breast Neoplasm
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 50+

Code: NCT05505643

Recruiting

Endometriosis Pain

for
Pelvic Pain, Endometriosis
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 12 - 45

Code: NCT06101303

Recruiting

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

for
Lymphatic Malformations
Location: St Louis MO, Cincinnati OH, Columbus OH, Cleveland OH,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT05948943

Phase 2, Phase 3, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: St Louis MO, Kansas City MO, Nashville TN, Chicago IL,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase 1, Phase 2, Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: St Louis MO, Iowa City IA, Nashville TN, Chicago IL,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase 3, Recruiting